STOCK TITAN

Sinovac Biotech, Ltd (SVA) Net Income by Year

SVA

Sinovac Biotech, Ltd reported a net loss of $198.8M in fiscal year 2025. This represents a decrease of 589.1% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Sinovac Biotech, Ltd has filed alongside them.

FY2025 annual
Net Income -$198.8M
YoY -589.1%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SVA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2520-FFY2420-FFY2320-FFY2220-FFY2120-FFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Net Income-$198.8M-589.1%$40.7M+401.4%-$13.5M-193.3%$14.5M-99.8%$8.1B+7259.1%$110.4M+145.7%$44.9M+106.3%$21.8M-15.6%$25.8M+4430.0%-$596K+57.9%-$1.4M+6.5%-$1.5M-120.4%$7.4M+139.7%-$18.7M-2119.6%-$845K

SVA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2520-FQ4'2420-FQ4'2320-FQ4'2220-FQ4'2120-FQ4'2010-KQ4'1910-KQ4'1810-KQ4'1710-KQ4'1610-KQ4'1510-KQ4'1410-K
Net IncomeN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Sinovac Biotech, Ltd financials

Frequently Asked Questions

What was Sinovac Biotech, Ltd's net income in fiscal year 2025?

Sinovac Biotech, Ltd reported a net loss of $198.8M in fiscal year 2025.

How fast is Sinovac Biotech, Ltd's net income growing?

Sinovac Biotech, Ltd (SVA) net income fell by 589.1% year over year, from $40.7M to -$198.8M in fiscal year 2025.

How has Sinovac Biotech, Ltd's net income changed over the years?

Across the 15 fiscal years this page covers, Sinovac Biotech, Ltd (SVA) net income went from -$845K in fiscal year 2011 to -$198.8M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Sinovac Biotech, Ltd (SVA) reported on that line in every period on record.